Pioneering a new approach to biological discovery

IPI blends academic exploration with industrial scalability
to tap the full potential of recombinant antibodies.

About usContact us
"Anti-glypicans" promotional image.
"Anti-glypicans" promotional image.
"Epitope tag antibodies" promotional image.
"Anti-Integrin antibodies" promotional image.

Our proteins power discovery

IPI is a nonprofit research hybrid that invests in high-throughput technologies and deep protein expertise to bring biological research up to speed.

About IPI →

Scientist wearing gloves and lab coat handles a tube containing antibodies.

Protein resources

We provide recombinant antibodies, protein tools and the data necessary to use them. View our protein collection.

Man working in cell biology lab.

High-throughput platform

Our technologies combine yeast display, cutting edge library design and automation to optimize protein quality and antibody binding. Get to know our platform.

Woman in glasses and lab coat holding pipette.

Scientific expertise

Our scientists take on transformative projects to explore the dark surfaceome and produce reliable reagents. Learn more about our research interests.

IPI in brief

Drawing of microscope.

Meeting research needs

IPI scientists deploy cutting-edge technologies and techniques, such as antibody engineering and a yeast display library, to tap the full potential of synthetic recombinant antibodies.

Basic drawing of antibody.

Best of both worlds

IPI combines deep academic expertise with industrial scalability, investing in high-throughput technologies and automation to bring biological research up to speed.

Figure representing business model.

Unique business model

IPI is a nonprofit institute with assured funding and the high-caliber expertise to support exploratory protein research.

Drawing of lightbulb.

Cross-disciplinary connections

IPI is poised to elevate life science communities, collaborating with biologists across specialties and training young scientists.

News from the lab

More IPI news →

A group of conference attendees gather around a table outside.

Mike Walden (second from left) gathers with scientists at the Lighting Up symposium on June 10, 2024. IPI photo by Sabrina Liu.
People

Michael Walden bridges two worlds as IPI’s director of commercialization

Driving commercial development at a nonprofit institution is a challenge. The business models are complex and typically reliant on revenue streams outside profits that benefit shareholders....

Read more
Glypicans: Explained
Core concepts

Glypicans: Explained

Hundreds of millions of years before humans evolved, a family of proteins came to be — first in worms, next in flies, then in mammals. The...

Read more
Deb Moshinsky stands in front of a lab machine wearing an IPI lab coat and safety goggles.

Deb Moshinsky in the IPI lab. IPI photo by Caitlin Faulds.
People

Deborah Moshinsky’s enterprising behind-the-scenes efforts ensure antibody quality

Deborah “Deb” Moshinsky is the type of process-motivated scientist that all labs require — but few are lucky to find. As the Director of Characterization and...

Read more
A group of scientists wearing lanyards pose for a photo after lunch at a scientific conference. A graphic at the front of the image reads, "Antibodies Roadshow: Exploring frontiers in molecular biology."

IPI photo by Trisha Gura.
Science news

IPI’s Antibodies Roadshow fosters neuroscience collaborations

The Institute for Protein Innovation (IPI) kicked off its inaugural “Antibodies Roadshow” on Saturday, October 5, during the Society for Neuroscience meeting in Chicago. The intimate...

Read more

Get in touch today

Contact us
Back To Top